EURONEXT-PAR$ABVX
Abivax SA · Q2 2025 earnings
Q2 2025 earnings · · After market close · Investor relations
Reports awaiting report
Abivax SA hasn't published Q2 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.
Most recent report Q1 2025
- Revenue
- $1.08M
- EPS
- -$0.90
FY2025 consensus Analyst consensus
- Revenue
- €6.56M
- EPS
- -€2.60
Revenue & EPS history
Abivax SA · Revenue · Quarterly
$1.08M
Q1 2025
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 3 quarterly earnings reports · overlaid with Q2 2025
+0.7%
Avg return
Earnings day
+1.8%
Avg return
5 days after
+16.9%
Avg return
30 days after
67%
2 / 3 earnings
Positive
+1.5%
Q2 2025
Best reaction
-0.2%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | +1.5% | -6.7% | +0.7% | |
| Q1 2025 | -0.2% | +11.6% | +30.1% | |
| Q4 2023 | +0.9% | +0.4% | +20.1% | |
| Q2 2023 | — | — | — | |
| Q4 2022 | — | — | — | |
| Q2 2022 | — | — | — | |
| Q4 2021 | — | — | — | |
| Q2 2021 | — | — | — | |
| Q4 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q2 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro